Contact

Forecasting & Financial Modeling.

Drive smart business decisions across the product lifecycle.

Get in touch with a Forecasting & Financial Modeling expert

What we do.

We provide a full suite of forecasting and financial modeling services for pharmaceutical companies. Our technical forecasting expertise in both deterministic and probabilistic domains support a variety of stakeholders, helping inform strategic, tactical, and investment decisions.

Whether for full-service or plug-and-play support, we can help you simplify the complexities of pharmaceutical forecasting through technical excellence, therapeutic area expertise, and data analytics.

Learn about our services

Our Forecasting and Pharma Financial Modeling services include:

Pipeline long-range strategy forecasts
In-line product operational forecasts
Valuation modeling
Business development and licensing forecasts
Dynamic disease modeling
Portfolio modeling
Value, pricing, and access scenario modeling

Our Financial Modeling & Forecasting expertise.

Strategy

Forecast development spanning epidemiology, Rx, and volume-based to support LRP
Modeling to inform due diligence decisions and risk/non-risk adjusted valuations
Scenario planning models
Simulation and portfolio modeling

Operational

Trend based forecast modeling for in-line products to support manufacturing and tactical planning
Dynamic disease epidemiology modeling to capture patient flow dynamics
Payer and channel economics and contracting models

Data Analytics

Analysis of market data sets
Real world data analysis across EMR, claims, and registry
Proprietary disease landscape, epidemiology, and analog data sets to inform forecast assumptions

Get to know some of our experts.

Vikram Gosain

Partner

Read bio

Sumit Tiwari

Director

Read bio

Michael Harvey

Featured case study

Dynamic disease modeling in NSCLC.

Our client required a comprehensive view of patient opportunity by granular sub-segments through a sophisticated model covering various dynamics.

View all case studies

Dynamic disease modeling in NSCLC

The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.

Latest thinking.

Get the latest insights and perspectives from our experts.

View all of our resources

Dynamic disease modeling in NSCLC

The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.

CAR-T roundtable discussion

Putnam’s panel of CGT experts help the clients in clinical decision-making, product on-boarding, emerging technologies, and key market trends.

Long-term strategy for cellular therapy

The organization engaged Putnam to support the development of 10-year strategy, focused on continuous innovation across all aspects of the business.

Unlocking the promise of cell therapies for solid tumors: Opportunities and challenges

Our cell and gene therapy experts offer a deep analysis on the current opportunities and challenges of cell therapies for solid tumors.

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Contact us today